Hengshan B. Wang
Key Laboratory For Chemistry And Molecular Engineering Of Medicinal Resources, Guangxi Key Laboratory Of Chemistry And Molecular Engineering Of Medicinal Resources
541004, China
541004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
Simultaneous Induction of Ferroptosis and Immunogenic Cell Death by TrxR-Targeted Pt(IV) Prodrugs for Chemoimmunotherapy of Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: April 17, 2026
Electrochemically Enabled Synthesis of Carboxylated Allenes via Carbon Dioxide Reduction.
Journal: Organic letters
Published: April 07, 2026
Hypervalent iodine-mediated highly mono- and di-selective etherification of 8-aminoquinolines at the C5 and C6 positions.
Journal: Organic & biomolecular chemistry
Published: November 14, 2025
Casbane diterpenoids from Euphorbiaceae suppresse neuroinflammation by regulating microglia polarization via inhibiting NF-κB signaling.
Journal: Bioorganic chemistry
Published: October 08, 2025
Novel norditerpene-phenanthrenes from Selaginella effusa inhibit T24 cell proliferation via blockade of the TRPV1/ STAT3/NF-κB pathway.
Journal: Fitoterapia
Published: September 23, 2025
Synthesis of 1,4-Naphthoquinone-Benzenesulfonamide Derivatives with Anti-H. Pylori Activity and Studies on their Mechanism of Action.
Journal: ChemMedChem
Published: August 25, 2025
Discovery of novel thiourea benzenesulfonamides based 1,8-naphthalimide derivatives as carbonic anhydrase IX inhibitors that induce ferroptosis and inhibit triple-negative breast cancer metastasis.
Journal: Bioorganic & medicinal chemistry
Published: May 09, 2025
Design, Synthesis and Antitumor Evaluation of Novel Dehydroabietic Acid Derivatives Bearing an α,β-Unsaturated Ketone Moiety.
Journal: Chemistry & biodiversity
Published: May 09, 2025
Discovery of novel combretastatin A4 derivatives as a microtubule targeting agent capable of inducing HepG-2 cell apoptosis via the mitochondria and ER stress mediated pathway.
Journal: Bioorganic chemistry
Published: April 24, 2025
Discovery of a Novel EF24 Analogue-Conjugated Pt(IV) Complex as Multi-Target Pt(IV) Prodrugs Aims to Enhance Anticancer Activity and Overcome Cisplatin Resistance.
Journal: Journal of medicinal chemistry
Published: February 20, 2025
Discovery of novel dual tubulin and MMPs inhibitors for the treatment of lung cancer and overcoming drug resistance.
Journal: European journal of medicinal chemistry
Published: November 22, 2024
Corrigendum to "Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis" [Eur. J. Med. Chem. 263 (2024) 115968].
Journal: European journal of medicinal chemistry
Published: October 22, 2024
Last Updated: 09/26/2026